Tavio Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,125
Closed -$820K 9
2020
Q1
$820K Sell
9,125
-216,585
-96% -$28M 1.18% 6
2019
Q4
$33.4M Buy
225,710
+82,377
+57% +$11.1M 12.3% 2
2019
Q3
$17.3M Buy
143,333
+24,976
+21% +$3.23M 9.12% 5
2019
Q2
$16M Sell
118,357
-40,856
-26% -$5.17M 6.49% 8
2019
Q1
$20.8M Sell
159,213
-60,770
-28% -$8.16M 7.65% 6
2018
Q4
$27.4M Buy
+219,983
New +$29.5M 11.37% 2
2018
Q3
Sell
-197,318
Closed -$20.2M 20
2018
Q2
$20.2M Buy
197,318
+67,385
+52% +$6.82M 6.86% 7
2018
Q1
$12.6M Buy
+129,933
New +$12.6M 5.94% 10

Other funds holding HCA

Tavio Capital's HCA Position: Q2 2020 in Review

Tavio Capital sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 9,125 shares — an estimated $820K sold.

Tavio Capital first reported a position in HCA in Q1 2018 and held it in 8 quarters. The position peaked at $33.4M in Q4 2019. 685 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

  • Tavio Capital reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
  • Tavio Capital sold 9,125 HCA Healthcare shares in Q2 2020, an estimated $820K.
  • Tavio Capital first reported a position in HCA Healthcare in Q1 2018 and held it in 8 quarters.
  • Tavio Capital's HCA Healthcare position peaked at $33.4M in Q4 2019.
  • 685 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on Tavio Capital's 13F filing for Q2 2020, filed 13 Aug 2020.